Dr. Alexa - Digital Cancer Therapy Assistant

Company - Who are we?

Takeda is a patient-driven, innovative and globally leading biopharmaceutical company. Our passion has its roots in Japan and in our more than 230-year history. We strive to help patients around the world achieve better health and a brighter future through groundbreaking medical innovations.

Takeda focuses its research and development activities on four therapeutic areas: Oncology, Gastroenterology, Rare Diseases and Neuroscience. In addition, we invest specifically in research and development in the areas of plasma-based therapies and vaccines. In this way, we want to remain one of the leading innovation partners in the industry in the future.

Patient first - this guiding principle stands above everything Takeda does. Only with a profound understanding of the needs of patients is it possible to develop products and services that sustainably improve the quality of life. That is why Takeda consistently puts the patient in the center. The voice of the patient has as much weight as that of the medical experts. In this way, Takeda can find more possibilities for support and disease management - at eye level with patients from research and development of innovative medicines to delivery, patient expertise is involved at all stages. Takeda maintains equal, trustworthy and transparent partnerships with patient organizations, conducts open dialogues with stakeholders and adheres to global guidelines and codes of conduct for dealing with patient organizations, patients and caregivers. Takeda is convinced that patient orientation is an indispensable prerequisite for the success and further development of therapies. Therefore, the central principle is "patient first".

What is Takeda's vision for the digital world of tomorrow?

For us, digitization is a tool and living environment to improve the health of patients in these areas:

• Research & Evidence
• Production - Quality Control, 3D Printing, Automation
• Diagnosis - AI and Big Data for diagnosis-supported systems, electronic patient file (also important for research)
• Therapy/Adherence - Apps/DiGAs

In the future, we see a universe of data that can be used for digital solutions without interfaces and in accordance with data protection guidelines, thus improving health. We see sovereign patients who can access their health data and gain transparent insight.
Digitization should broaden access to knowledge and healthcare applications, be intuitive and inclusive.

Here you can find all background information about a big collaboration with Amazon Web Services (AWS) and Accenture. Together they have signed a five-year agreement to accelerate Takeda's digital transformation:

 "My vision is that, in less than ten years, every Takeda employee will be empowered by an artificial intelligence assistant to help make better decisions, enabling us to deliver transformative therapies and better experiences to patients, physicians and payers faster than previously possible. Together, Accenture and AWS will propel Takeda further than we could alone to make this vision a reality," said Christophe Weber, Takeda president and chief executive officer.

What values are important when it comes to the digital future?

"Patient, Trust, Reputation, Business" - PTRB - they also retain their validity in the context of digitization. This is what makes them strong and our actions based on these values reliable.

What potential does Takeda have to help shape a digital and sustainable future together with the digital generation?

Takeda's self-image as an international company can be described with these keywords: hybrid work, cloud-based etc. / open mind-set/ patient, people, planet approach

• Research & Evidence - Focus on unmet need
• Production - Quality Control, 3D Printing, Automation (Oranienburg)
• Diagnostics - AI and Big Data for diagnosis-supported systems (e.g. Global Commission, cooperation with ADA Health tbd.)
• Therapy/Adherence - Apps/DiGAs (e.g. CED Forum App, Hackathon)